Vidente CEO Change: Appointment of New CEO Baek Seung-ho
Vidente announced that CEO Im Jung-geun resigned on June 30, 2026 due to personal reasons, and Baek Seung-ho has been appointed as the new CEO.
New CEO Baek Seung-ho previously served as Vice President at Hanall Biopharma and CEO at JW Shinyak.
This management change does not involve any capital or dividend policy adjustments.
[AI Summary]The CEO change at Vidente is a routine replacement due to personal reasons, with no impact on capital structure or funding plans, making it neutral for the stock price. The new CEO's industry experience may be viewed positively for management stability.